Tudor Investment Corp’s Sage Therapeutics SAGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-108,377
Closed -$988K 3813
2025
Q2
$988K Sell
108,377
-34,537
-24% -$254K ﹤0.01% 2133
2025
Q1
$1.14M Buy
+142,914
New +$1.05M ﹤0.01% 1737
2024
Q3
Sell
-29,963
Closed -$325K 3051
2024
Q2
$325K Buy
29,963
+16,666
+125% +$214K ﹤0.01% 1984
2024
Q1
$249K Sell
13,297
-16,641
-56% -$384K ﹤0.01% 1938
2023
Q4
$649K Sell
29,938
-20,726
-41% -$411K 0.01% 1652
2023
Q3
$1.04M Buy
50,664
+29,841
+143% +$862K 0.01% 1278
2023
Q2
$979K Sell
20,823
-10,500
-34% -$522K 0.01% 1326
2023
Q1
$1.31M Buy
+31,323
New +$1.35M 0.02% 1026
2022
Q4
Sell
-17,207
Closed -$674K 2788
2022
Q3
$674K Sell
17,207
-19,958
-54% -$771K 0.01% 1185
2022
Q2
$1.2M Buy
+37,165
New +$1.25M 0.03% 779
2021
Q1
Sell
-4,978
Closed -$431K 1818
2020
Q4
$431K Buy
+4,978
New +$367K 0.01% 1009
2020
Q3
Sell
-5,207
Closed -$217K 1514
2020
Q2
$217K Buy
+5,207
New +$189K 0.01% 1004
2020
Q1
Sell
-8,166
Closed -$590K 1292
2019
Q4
$590K Buy
+8,166
New +$1M 0.03% 667
2018
Q3
Sell
-5,341
Closed -$836K 1236
2018
Q2
$836K Buy
+5,341
New +$838K 0.03% 499
2018
Q1
Sell
-1,408
Closed -$232K 1208
2017
Q4
$232K Sell
1,408
-3,407
-71% -$330K 0.01% 918
2017
Q3
$300K Buy
4,815
+1,860
+63% +$146K 0.01% 829
2017
Q2
$235K Buy
+2,955
New +$214K 0.01% 834
2016
Q4
Sell
-15,449
Closed -$711K 1582
2016
Q3
$711K Buy
15,449
+6,076
+65% +$247K 0.02% 559
2016
Q2
$282K Buy
+9,373
New +$313K 0.01% 1206
2015
Q3
Sell
-3,131
Closed -$229K 1721
2015
Q2
$229K Buy
+3,131
New +$201K 0.01% 1273

Other funds holding SAGE